Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar;52(3):315-328.
doi: 10.1007/s00256-022-04113-6. Epub 2022 Jul 9.

PET/MR of pediatric bone tumors: what the radiologist needs to know

Affiliations
Review

PET/MR of pediatric bone tumors: what the radiologist needs to know

Jennifer Padwal et al. Skeletal Radiol. 2023 Mar.

Abstract

Integrated 2-deoxy-2-[fluorine-18]fluoro-D-glucose (18F-FDG) positron emission tomography (PET)/magnetic resonance (MR) imaging can provide "one stop" local tumor and whole-body staging in one session, thereby streamlining imaging evaluations and avoiding duplicate anesthesia in young children. 18F-FDG PET/MR scans have the benefit of lower radiation, superior soft tissue contrast, and increased patient convenience compared to 18F-FDG PET/computerized tomography scans. This article reviews the 18F-FDG PET/MR imaging technique, reporting requirements, and imaging characteristics of the most common pediatric bone tumors, including osteosarcoma, Ewing sarcoma, primary bone lymphoma, bone and bone marrow metastases, and Langerhans cell histiocytosis.

Keywords: Bone sarcoma; Magnetic resonance; PET/MR; Pediatric cancer; Positron emission tomography.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement: The authors declare no potential conflicts of interest.

Figures

Fig 1.
Fig 1.
Example of the 18F-FDG-PET/MR Imaging Workflow
Fig. 2.
Fig. 2.
Telangiectatic osteosarcoma of the left tibia in an 11-year-old male presenting with left leg pain and mass. a. Lateral radiograph demonstrates an expansile mixed lucent and sclerotic lesion of the proximal left tibial metaphysis extending into the diaphysis. There is moderate cortical destruction with sunburst type periosteal reaction and a partially calcified anterior soft tissue mass. b. Sagittal T1-weighted MR image showing a heterogeneously hypointense expansile tumor of the proximal tibia with extensive cortical destruction and aggressive periosteal reaction. c. PET/MR axial T1-weighted fat suppressed fused image demonstrating diffuse heterogenous hypermetabolism of the mass (SUV max 6.2). d. Axial T2-weighted fat suppressed MR image showing numerous fluid-fluid levels throughout the mass.
Fig. 3.
Fig. 3.
Intermediate grade periosteal chondroblastic osteosarcoma of the left tibia in a 13-year-old female presenting with left lower extremity pain. a. Lateral radiograph and b. sagittal CT image of the left tibia/fibula showing a cortical based lesion involving the anterior proximal tibial diaphysis with aggressive periosteal bone formation and scalloping of the underlying cortex. c. PET/MR sagittal T1-weighted fused image demonstrating a broad based, hypermetabolic soft tissue mass along the anterior proximal diaphysis of the left tibia (SUV max 12.6) with thickening of the underlying anterior cortex. d. Sagittal T1-weighted fat-suppressed post contrast MR image and e. axial PD-weighted fat suppressed MR image showing heterogenous enhancement/hyperintensity of the anterior soft tissue component with small amount of medullary involvement posterior to the mass.
Fig. 4.
Fig. 4.
Left fibula Ewing Sarcoma in a 10-year-old female patient presenting with a 3–4 month history of left foot drop, left lower extremity pain and paresthesias, and a large nontender mass in her left lower leg. a. Coronal whole body T2-weighted MR, b. PET/MR coronal T2-weighted fused, and c. PET/MR axial T1-weighted fat-suppressed postcontrast images showing a primary T2 heterogenously hyperintense mass arising from the left proximal fibular diaphysis that demonstrates significant 18F-FDG PET avidity (SUV max 5.6) and enhancement. d. Sagittal T1-weighted and e. T1-weighted fat-suppressed postcontrast MR images of the distal fibula showing discrete T1 hypointense lesions that enhance on postcontrast images, consistent with intramedullary skip lesions.
Fig. 5.
Fig. 5.
Left scapula Ewing sarcoma in a 15-year- old male presenting with left scapular mass. a. PET/MR whole body coronal MIP and b. PET/MR whole body coronal T1-weighted fat suppressed fused images showing an intensely 18F-FDG-avid mass centered in the left scapula (SUV max 7.1) with central necrosis. c. Prone axial T2-weighted fat suppressed MR image showing a lobulated, hyperintense mass in the left scapula with large associated soft tissue component and surrounding edema infiltrates the supraspinatus, infraspinatus, and subscapularis muscles. d. Sagittal T1-weighted fat-saturated postcontrast MR image of the left scapula showing enhancement of the mass and infiltration of the surrounding rotator cuff musculature.
Fig. 6.
Fig. 6.
Langerhans cell histiocytosis of the left scapula discovered on a skeletal survey in a 2-year-old male presenting with right facial nerve palsy and a mass on the right forehead. a. Frontal radiograph of the left scapula showing an expansile, lytic lesion involving the acromion, glenoid, and scapular body with a normal left humerus. b. PET/MR whole body coronal MIP, c. PET/MR whole body coronal T2-weighted fused, and d. axial T2-weighted fat-suppressed MR images showing a highly 18F-FDG-avid (SUV max 15.8), T2 hypointense lesion involving the left scapular acromion and body.

Similar articles

Cited by

References

    1. Hardin AP, Hackell JM, Simon GR, Boudreau ADA, Baker CN, Barden GA, et al. Age limit of pediatrics. Pediatrics. 2017;140:3–5. - PubMed
    1. Schäfer JF, Gatidis S, Schmidt H, Gückel B, Bezrukov I, Pfannenberg CA, et al. Simultaneous whole-body PET/MR imaging in comparison to PET/CT in pediatric oncology: Initial results. Radiology. Radiological Society of North America Inc; 2014;273:220–31. - PubMed
    1. Lyons K, Seghers V, Sorensen JIL, Zhang W, Paldino MJ, Krishnamurthy R, et al. Comparison of Standardized Uptake Values in Normal Structures Between PET/CT and PET/MRI in a Tertiary Pediatric Hospital: A Prospective Study. AJR Am J Roentgenol. 2015;205:1094–101. - PubMed
    1. Buchbender C, Heusner TA, Lauenstein TC, Bockisch A, Antoch G. Oncologic PET/MRI, part 2: bone tumors, soft-tissue tumors, melanoma, and lymphoma. J Nucl Med. 2012;53:1244–52. - PubMed
    1. Rashidi A, Baratto L, Theruvath AJ, Greene EB, Hawk KE, Lu R, et al. Diagnostic Accuracy of 2-[18F]FDG-PET and Whole-Body DW-MRI for The Detection of Bone Marrow Metastases in Children and Young Adults. Eur Radiol. 2022;(In press). - PMC - PubMed